Page 33 - manuscript_ijb05590

12. Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer.
2018;18(7):407-418. doi:10.1038/s41568-018-0007-6

13. Xu R, Zhou X, Wang S, Trinkle C. Tumor organoid models in precision medicine
and investigating cancer-stromal interactions. Pharmacol Ther. 2021;218:107668.
doi:10.1016/j.pharmthera.2020.107668

14. Quintard C, Tubbs E, Jonsson G, et al. A microfluidic platform integrating
functional vascularized organoids-on-chip. Nat Commun. 2024;15(1):1452.
doi:10.1038/s41467-024-45710-4

15. Yu F, Hunziker W, Choudhury D. Engineering microfluidic organoid-on-a-chip
platforms. Micromachines. 2019;10(3):165. doi:10.3390/mi10030165

16. Zhang J, Tavakoli H, Ma L, Li X, Han L, Li X. Immunotherapy discovery on
tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Adv Drug Deliv Rev. 2022;187:114365. doi:10.1016/j.addr.2022.114365

17. Li C, Holman JB, Shi Z, Qiu B, Ding W. On-chip modeling of tumor evolution:
advances, challenges and opportunities. Mater Today Bio. 2023;21:100724.
doi:10.1016/j.mtbio.2023.100724

18. Shirure VS, Hughes CCW, George SC. Engineering vascularized organoid-on-a-
chip models. Annu Rev Biomed Eng. 2021;23:141-167. doi:10.1146/annurev-
bioeng-090120-094330

19. Zou Z, Lin Z, Wu C, et al. Micro-engineered organoid-on-a-chip based on
mesenchymal stromal cells to predict immunotherapy responses of HCC patients.
Adv Sci Weinh Baden-Wurtt Ger. 2023;10(27):e2302640.
doi:10.1002/advs.202302640

20. Du Y, Wang YR, Bao QY, et al. Personalized vascularized tumor organoid-on-a-
chip for tumor metastasis and therapeutic targeting assessment. Adv Mater
Deerfield Beach Fla. 2025;37(6):e2412815. doi:10.1002/adma.202412815

21. Ayuso JM, Rehman S, Virumbrales-Munoz M, et al. Microfluidic tumor-on-a-chip
model to evaluate the role of tumor environmental stress on NK cell exhaustion.
Sci Adv. 2021;7(8):eabc2331. doi:10.1126/sciadv.abc2331

22. Gil JF, Moura CS, Silverio V, Gonçalves G, Santos HA. Cancer models on chip:
paving the way to large-scale trial applications. Adv Mater Deerfield Beach Fla.
2023;35(35):e2300692. doi:10.1002/adma.202300692

23. Ju M, Jin Z, Yu X, et al. Gastric cancer models developed via GelMA 3D
bioprinting accurately mimic cancer hallmarks, tumor microenvironment features,
and drug responses. Small Weinh Bergstr Ger. 2025;21(8):e2409321.
doi:10.1002/smll.202409321
32